Zobrazeno 1 - 10
of 30
pro vyhledávání: ''
Autor:
Zackary D. Goff, Anuradha Godishala, Paul J. Hauptman, Susan M. Joseph, Jerrica E. Shuster, John T. Chibnall, Andrija Vidic
Publikováno v:
International Journal of Cardiology. 274:245-247
Background Targeted treatment for decompensated right heart failure (RHF) with or without left heart failure is lacking. Vasopressin antagonists (vaptans) may offer an option by increasing urine output and fluid mobilization when used in acute decomp
Autor:
Masahiko Ochiai, Shinsuke Nanto, Shigenori Ito, Hiroaki Takashima, Akira Miyamoto, Ryuta Asano, Toshiya Muramatsu, Hiroshi Ohira, Yutaka Matsuyama, Takahisa Yamada, Masato Nakamura, Hiroshi Fujita, Yoshio Yasumura, Hidenari Hozawa, Nobuo Shiode, Satoru Suwa, Yoshiaki Tsukamoto, Hisayuki Okada, Hiroyoshi Yokoi, Hiroaki Mukawa, Takayuki Ogawa, Kazuya Kawai, Masaki Awata
Publikováno v:
International Journal of Cardiology. 208:4-12
Background Three-year clinical follow-up of patients with diabetes mellitus (DM) in the Japan-Drug Eluting Stents Evaluation; a Randomized Trial (J-DESsERT) using 2 different drug eluting stents (DES). A recent study demonstrated that efficacy of sir
Autor:
Chern En Chiang, Cheng Hsueh Wu, Chiu Mei Yeh, Shing Jong Lin, Kang Ling Wang, Su Jung Chen, Tzeng Ji Chen, Tze Fan Chao, Chi Ming Huang, Chia Jen Liu
Publikováno v:
International Journal of Cardiology. 177:86-90
Saxagliptin was associated with an increased risk of hospitalization for heart failure (HHF) in diabetic patients with high cardiovascular risk. This study assessed the risk of HHF during an exposure to sitagliptin in general diabetic patients.In Tai
Autor:
Ilaria Cavallari, Naveen Deenadayalu, Minggao Shi, Christian T. Ruff, Robert P. Giugliano, Howard Rutman, Elliott M. Antman, Francesco Nordio, Hans Lanz, Michele Mercuri, Eugene Braunwald
Publikováno v:
International journal of cardiology. 257
Background Patients with atrial fibrillation (AF) who interrupt anticoagulation are at high risk of thromboembolism and death. Methods and results Patients enrolled in the ENGAGE AF-TIMI 48 trial (randomized comparison of edoxaban vs. warfarin) who i
Autor:
H. Boenigk, Alexander Schmeisser, Conrad Genz, Ruediger C. Braun-Dullaeus, Hans D. Esperer, Joerg Herold, Samir M. Said, Kathrin Kluba, Anne K. Wiedemann
Publikováno v:
International Journal of Cardiology. 167:2600-2604
Background Dronedarone is a new antiarrhythmic agent that has only recently been approved for the therapy of atrial fibrillation (AF). Results regarding a broader spectrum of patients and experience accumulated in clinical practice are still very sca
Autor:
Bastiaan Geelhoed, Pim van der Harst, Folkert W. Asselbergs, Michiel Rienstra, Isabelle C. Van Gelder, Henri M. H. Spronk, Bart A. Mulder
Publikováno v:
International Journal of Cardiology, 272, 208-210. Elsevier Ireland Ltd
International Journal of Cardiology, 272, 208-210. ELSEVIER IRELAND LTD
International Journal of Cardiology, 272, 208. Elsevier Ireland Ltd
International Journal of Cardiology, 272, 208-210. ELSEVIER IRELAND LTD
International Journal of Cardiology, 272, 208. Elsevier Ireland Ltd
Background: Tissue-type plasminogen activator (TPA) and plasminogen activator inhibitor-1 (PAI-1) have been shown to be associated with increased risk for stroke, however, the association with incident atrial fibrillation (AF) is unknown.Methods: We
Autor:
Kenji Kawajiri, Yusuke Nakatsu, Ryohei Yoshikawa, Tadanori Aizawa, Mitsuru Muto, Takefumi Ozaki, Takayuki Ogawa, Nozomu Kawashima, Masatoshi Suzuki, Shinichi Usui, Makoto Kadotani, Haruo Kamiya, Kenya Nasu, Yoshifumi Kashima, Masaru Yamaki, Yuji Oikawa, Hiroshi Ota, Atsunori Okamura, Jun Yamashita, Satoru Tohara, Ren Kawaguchi, Takahiko Suzuki, Yoshihiro Takeda, Yasuhiro Uchida
Publikováno v:
International Journal of Cardiology. 166:187-192
Background In the treatment of bifurcation lesions, routine stenting of both branches has thus far failed to demonstrate a clear clinical advantage over a provisional one-stent strategy. On the other hand, large scale data evaluating different stent
Autor:
Takayoshi Ohba, Kyoichi Mizuno, Osamu Kurihara, Daisuke Murakami, Masanori Yamamoto, Masamichi Takano, Koji Murai, Yoshihiko Seino, Nakahisa Kimata, Toru Inami
Publikováno v:
International Journal of Cardiology. 166:181-186
Although several clinical trials have shown the superior efficacy and safety of second-generation everolimus-eluting stents (EES) in comparison with first-generation paclitaxel-eluting stents (PES), the differences in the vascular healing process bet
Autor:
Arthur da Silva Gomes, Mayla Cardoso Fernandes Toffolo, Aline Silva de Aguiar, C.C.S. Alves, S.C.P.L Dutra, Luan Cristian da Silva, Erick Esteves de Oliveira, Ana Paula Ferreira, Caroline de Souza Almeida, H.V Van Keulen
Publikováno v:
International journal of cardiology. 230
Introduction Nitric oxide (NO) modulates inflammatory reactions, having beneficial or toxic effects depending on the concentration. Its elevation can cause proinflammatory effects amplifying the inflammatory process with the participation of cytokine
Autor:
Giuseppe Marazzi, Maurizio Volterrani, Rosalba Massaro, Mitja Lainscak, Francesco Pelliccia, Luca Cacciotti, Alessandra Tanzilli, Martina Di Iorio, Sara Poggi, Giuseppe M.C. Rosano, Giuseppe Campolongo
Publikováno v:
International journal of cardiology. 222
Background The ultimate goal of antihypertensive therapy is cardiovascular risk (CVR) reduction. The aim of this study was to compare the efficacy and safety of once-daily fixed combination (ODFC) versus free-drug combination (FDC) of 3antihypertensi